FOXQ1 and nasopharyngeal carcinoma: To confirm whether Foxq1 exerts a VM promoting effect through EGFR in NPC cells, the Foxq1 overexpressing NPC cells were pre-treated with Erlotinib (EGFR inhibitor) for 24 h, then the capacity of VM formation was detected by 3D culture.